144 related articles for article (PubMed ID: 26070388)
1. Protein-nanoparticle interactions evaluation by immunomethods: Surfactants can disturb quantitative determinations.
Fornaguera C; Calderó G; Solans C; Vauthier C
Eur J Pharm Biopharm; 2015 Aug; 94():284-90. PubMed ID: 26070388
[TBL] [Abstract][Full Text] [Related]
2. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
3. Comparative examination of adsorption of serum proteins on HSA- and PLGA-based nanoparticles using SDS-PAGE and LC-MS.
Gossmann R; Fahrländer E; Hummel M; Mulac D; Brockmeyer J; Langer K
Eur J Pharm Biopharm; 2015 Jun; 93():80-7. PubMed ID: 25813886
[TBL] [Abstract][Full Text] [Related]
4. Investigating the Influence of Polysorbate 20/80 and Polaxomer P188 on the Surface & Interfacial Properties of Bovine Serum Albumin and Lysozyme.
Begum F; Amin S
Pharm Res; 2019 May; 36(7):107. PubMed ID: 31111248
[TBL] [Abstract][Full Text] [Related]
5. Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona.
Vauthier C; Lindner P; Cabane B
Colloids Surf B Biointerfaces; 2009 Mar; 69(2):207-15. PubMed ID: 19135340
[TBL] [Abstract][Full Text] [Related]
6. Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies.
Fornaguera C; Calderó G; Mitjans M; Vinardell MP; Solans C; Vauthier C
Nanoscale; 2015 Apr; 7(14):6045-58. PubMed ID: 25766431
[TBL] [Abstract][Full Text] [Related]
7. Impact of poly(lactic-co-glycolic acid) nanoparticle surface charge on protein, cellular and haematological interactions.
Pillai GJ; Greeshma MM; Menon D
Colloids Surf B Biointerfaces; 2015 Dec; 136():1058-66. PubMed ID: 26590899
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a combined drug-delivery system for proteins assembled with polymeric nanoparticles and porous microspheres; characterization and protein integrity studies.
Alcalá-Alcalá S; Benítez-Cardoza CG; Lima-Muñoz EJ; Piñón-Segundo E; Quintanar-Guerrero D
Int J Pharm; 2015 Jul; 489(1-2):139-47. PubMed ID: 25936624
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of Proteins Using an Array of Surfactant-Stabilized Gold Nanoparticles.
Rogowski JL; Verma MS; Gu FX
Langmuir; 2016 Aug; 32(30):7621-9. PubMed ID: 27399345
[TBL] [Abstract][Full Text] [Related]
10. Surface modification of HSA containing magnetic PLGA nanoparticles by poloxamer to decrease plasma protein adsorption.
Shubhra QTH; Tóth J; Gyenis J; Feczkó T
Colloids Surf B Biointerfaces; 2014 Oct; 122():529-536. PubMed ID: 25092588
[TBL] [Abstract][Full Text] [Related]
11. Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles.
Jain D; Athawale R; Bajaj A; Shrikhande S; Goel PN; Gude RP
Colloids Surf B Biointerfaces; 2013 Sep; 109():59-67. PubMed ID: 23608470
[TBL] [Abstract][Full Text] [Related]
12. Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A.
Schuster T; Mühlstein A; Yaghootfam C; Maksimenko O; Shipulo E; Gelperina S; Kreuter J; Gieselmann V; Matzner U
J Control Release; 2017 May; 253():1-10. PubMed ID: 28215668
[TBL] [Abstract][Full Text] [Related]
13. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.
Lai P; Daear W; Löbenberg R; Prenner EJ
Colloids Surf B Biointerfaces; 2014 Jun; 118():154-63. PubMed ID: 24769392
[TBL] [Abstract][Full Text] [Related]
14. Adsorption of plasma proteins on uncoated PLGA nanoparticles.
Sempf K; Arrey T; Gelperina S; Schorge T; Meyer B; Karas M; Kreuter J
Eur J Pharm Biopharm; 2013 Sep; 85(1):53-60. PubMed ID: 23395970
[TBL] [Abstract][Full Text] [Related]
15. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.
Petri B; Bootz A; Khalansky A; Hekmatara T; Müller R; Uhl R; Kreuter J; Gelperina S
J Control Release; 2007 Jan; 117(1):51-8. PubMed ID: 17150277
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of poly(vinyl alcohol) mediated prevention of aggregation and stabilization of insulin in nanoparticles.
Rawat S; Gupta P; Kumar A; Garg P; Suri CR; Sahoo DK
Mol Pharm; 2015 Apr; 12(4):1018-30. PubMed ID: 25644480
[TBL] [Abstract][Full Text] [Related]
18. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.
Santander-Ortega MJ; Jódar-Reyes AB; Csaba N; Bastos-González D; Ortega-Vinuesa JL
J Colloid Interface Sci; 2006 Oct; 302(2):522-9. PubMed ID: 16887138
[TBL] [Abstract][Full Text] [Related]
19. Modulation of protein adsorption by poloxamer 188 in relation to polysorbates 80 and 20 at solid surfaces.
Kim HL; McAuley A; Livesay B; Gray WD; McGuire J
J Pharm Sci; 2014 Apr; 103(4):1043-9. PubMed ID: 24532194
[TBL] [Abstract][Full Text] [Related]
20. Design and in vitro evaluation of biocompatible dexamethasone-loaded nanoparticle dispersions, obtained from nano-emulsions, for inhalatory therapy.
Fornaguera C; Llinàs M; Solans C; Calderó G
Colloids Surf B Biointerfaces; 2015 Jan; 125():58-64. PubMed ID: 25437064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
